Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Comparison of Unenhanced and Gadolinium-Enhanced Imaging in Multiple Sclerosis: Is Contrast Needed for Routine Follow-Up MRI?

Sadigh G, Saindane AM, Waldman AD, Lava NS, Hu R.

AJNR Am J Neuroradiol. 2019 Sep;40(9):1476-1480. doi: 10.3174/ajnr.A6179. Epub 2019 Aug 22.

PMID:
31439627
2.

Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis.

Fox RJ, Coffey CS, Conwit R, Cudkowicz ME, Gleason T, Goodman A, Klawiter EC, Matsuda K, McGovern M, Naismith RT, Ashokkumar A, Barnes J, Ecklund D, Klingner E, Koepp M, Long JD, Natarajan S, Thornell B, Yankey J, Bermel RA, Debbins JP, Huang X, Jagodnik P, Lowe MJ, Nakamura K, Narayanan S, Sakaie KE, Thoomukuntla B, Zhou X, Krieger S, Alvarez E, Apperson M, Bashir K, Cohen BA, Coyle PK, Delgado S, Dewitt LD, Flores A, Giesser BS, Goldman MD, Jubelt B, Lava N, Lynch SG, Moses H, Ontaneda D, Perumal JS, Racke M, Repovic P, Riley CS, Severson C, Shinnar S, Suski V, Weinstock-Guttman B, Yadav V, Zabeti A; NN102/SPRINT-MS Trial Investigators.

N Engl J Med. 2018 Aug 30;379(9):846-855. doi: 10.1056/NEJMoa1803583.

3.

Design, rationale, and baseline characteristics of the randomized double-blind phase II clinical trial of ibudilast in progressive multiple sclerosis.

Fox RJ, Coffey CS, Cudkowicz ME, Gleason T, Goodman A, Klawiter EC, Matsuda K, McGovern M, Conwit R, Naismith R, Ashokkumar A, Bermel R, Ecklund D, Koepp M, Long J, Natarajan S, Ramachandran S, Skaramagas T, Thornell B, Yankey J, Agius M, Bashir K, Cohen B, Coyle P, Delgado S, Dewitt D, Flores A, Giesser B, Goldman M, Jubelt B, Lava N, Lynch S, Miravalle A, Moses H, Ontaneda D, Perumal J, Racke M, Repovic P, Riley C, Severson C, Shinnar S, Suski V, Weinstock-Gutman B, Yadav V, Zabeti A.

Contemp Clin Trials. 2016 Sep;50:166-77. doi: 10.1016/j.cct.2016.08.009. Epub 2016 Aug 10.

4.

Factors associated with benign multiple sclerosis in the New York State MS Consortium (NYSMSC).

Zivadinov R, Cookfair DL, Krupp L, Miller AE, Lava N, Coyle PK, Goodman AD, Jubelt B, Lenihan M, Herbert J, Gottesman M, Snyder DH, Apatoff BR, Teter BE, Perel AB, Munschauer F, Weinstock-Guttman B.

BMC Neurol. 2016 Jul 15;16:102. doi: 10.1186/s12883-016-0623-2.

5.

Blood B Cell and Regulatory Subset Content in Multiple Sclerosis Patients.

Habib J, Deng J, Lava N, Tyor W, Galipeau J.

J Mult Scler (Foster City). 2015 May;2(2). pii: 1000139.

6.

False-positive SCA8 gene test in a patient with pathologically proven multiple system atrophy.

Factor SA, Qian J, Lava NS, Hubbard JD, Payami H.

Ann Neurol. 2005 Mar;57(3):462-3. No abstract available.

PMID:
15732096
7.

Multiple sclerosis characteristics in African American patients in the New York State Multiple Sclerosis Consortium.

Weinstock-Guttman B, Jacobs LD, Brownscheidle CM, Baier M, Rea DF, Apatoff BR, Blitz KM, Coyle PK, Frontera AT, Goodman AD, Gottesman MH, Herbert J, Holub R, Lava NS, Lenihan M, Lusins J, Mihai C, Miller AE, Perel AB, Snyder DH, Bakshi R, Granger CV, Greenberg SJ, Jubelt B, Krupp L, Munschauer FE, Rubin D, Schwid S, Smiroldo J; New York State Multiple Sclerosis Consortium.

Mult Scler. 2003 Jun;9(3):293-8.

PMID:
12814178
8.

Focal myopathy as a cause of anterocollis in Parkinsonism.

Lava NS, Factor SA.

Mov Disord. 2001 Jul;16(4):754-6.

PMID:
11481704
9.

G8363A mutation in the mitochondrial DNA transfer ribonucleic acidLys gene: another cause of Leigh syndrome.

Shtilbans A, Shanske S, Goodman S, Sue CM, Bruno C, Johnson TL, Lava NS, Waheed N, DiMauro S.

J Child Neurol. 2000 Nov;15(11):759-61.

PMID:
11108511
10.

A profile of multiple sclerosis: the New York State Multiple Sclerosis Consortium.

Jacobs LD, Wende KE, Brownscheidle CM, Apatoff B, Coyle PK, Goodman A, Gottesman MH, Granger CV, Greenberg SJ, Herbert J, Krupp L, Lava NS, Mihai C, Miller AE, Perel A, Smith CR, Snyder DH.

Mult Scler. 1999 Oct;5(5):369-76.

PMID:
10516782
11.

Central deafness in a young child with Moyamoya disease: paternal linkage in a Caucasian family: two case reports and a review of the literature.

Setzen G, Cacace AT, Eames F, Riback P, Lava N, McFarland DJ, Artino LM, Kerwood JA.

Int J Pediatr Otorhinolaryngol. 1999 Apr 25;48(1):53-76. Review.

PMID:
10365973
12.

Familial X-linked myalgia and cramps: a nonprogressive myopathy associated with a deletion in the dystrophin gene.

Gospe SM Jr, Lazaro RP, Lava NS, Grootscholten PM, Scott MO, Fischbeck KH.

Neurology. 1989 Oct;39(10):1277-80.

PMID:
2677830
13.

Treatment of carpal tunnel syndrome with vitamin B6: a double-blind study.

Stransky M, Rubin A, Lava NS, Lazaro RP.

South Med J. 1989 Jul;82(7):841-2.

PMID:
2749352
14.

Ethylene glycol intoxication: a new stage in the clinical syndrome.

Factor SA, Lava NS.

N Y State J Med. 1987 Mar;87(3):179-80. No abstract available.

PMID:
3472114
15.

Inclusion body myositis: case reports and a reappraisal of an underrecognized type of inflammatory myopathy.

Lazaro RP, Barron KD, Dentinger MP, Lava NS.

Mt Sinai J Med. 1986 Feb;53(2):137-44. No abstract available.

PMID:
3010093
16.

D-penicillamine-induced neuromuscular disease in guinea pigs.

McVicker JH, Lava NS, Mittag TW, Ringel SP.

Exp Neurol. 1982 Apr;76(1):46-57. No abstract available.

PMID:
7084364
17.

Polymyositis with eosinophilia and mononeuropathy multiplex.

Strosberg JM, Lava NS.

J Rheumatol. 1981 May-Jun;8(3):523-6. No abstract available.

PMID:
7288774
18.

Immune complex vasculitis, polymyositis, and hyperglobulinemic purpura.

Ringel SP, Thorne EG, Phanuphak P, Lava NS, Kohler PS.

Neurology. 1979 May;29(5):682-9.

PMID:
155783
19.

Late-onset X-linked recessive spinal and bulbar muscular atrophy.

Ringel SP, Lava NS, Treihaft MM, Lubs ML, Lubs HA.

Muscle Nerve. 1978 Jul-Aug;1(4):297-307.

PMID:
571530
20.

Recurrence of thymoma and myasthenia gravis after 19 years. A case report.

Lava NS, Rodichok L, Martinez LB.

Neurology. 1976 Jul;26(7):696-8.

PMID:
945517

Supplemental Content

Support Center